Safety and efficacy of concurrent carboplatin or cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma

被引：0
|
作者：
Marinho, Joana [1 ]
Laranja, Andre [2 ]
Leao, Ines [1 ]
Joaquim, Ana [1 ]
Vieira, Claudia [3 ]
Dinis, Jose [3 ]
Soares, Andre [2 ]
Moreira, Diana [2 ]
机构：
[1] Ctr Hosp Vila Nova de Gaia Espinho, Med Oncol Dept, Vila Nova De Gaia, Portugal
[2] Inst Portugues Oncol Porto, Radiat Oncol Dept, Porto, Portugal
[3] Inst Portugues Oncol Porto, Med Oncol Dept, Porto, Portugal
来源：
ORAL ONCOLOGY | 2021年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-188
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Carboplatin versus cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma.
    Thanikachalam, Kannan
    Krishnan, Jayasree
    Siddiqui, Farzan
    Ali, Haythem Y.
    Sheqwara, Jawad
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Carboplatin Versus Cetuximab Chemoradiation in Cisplatin Ineligible Patients with Locally Advanced p16 Negative Head and Neck Squamous Cell Carcinoma
    Barney, C.
    Healy, E.
    Zamora, P.
    Aljabban, J.
    Walston, S. A., Jr.
    Diavolitsis, V. M.
    Blakaj, D. M.
    Wobb, J. L.
    Mitchell, D. L.
    Grecula, J. C.
    Neki, A.
    Rupert, R.
    Savvides, P.
    Bhatt, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E322 - E323
  • [3] Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Hamauchi, Satoshi
    Yokota, Tomoya
    Mizumachi, Takatsugu
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Nishimura, Tetsuo
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    Homma, Akihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 468 - 475
  • [4] Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Satoshi Hamauchi
    Tomoya Yokota
    Takatsugu Mizumachi
    Yusuke Onozawa
    Hirofumi Ogawa
    Tsuyoshi Onoe
    Tomoyuki Kamijo
    Yoshiyuki Iida
    Tetsuo Nishimura
    Tetsuro Onitsuka
    Hirofumi Yasui
    Akihiro Homma
    International Journal of Clinical Oncology, 2019, 24 : 468 - 475
  • [5] Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Tanaka, Ryoko
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Togashi, Takafumi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1133 - 1141
  • [6] Cisplatin or Carboplatin in locally advanced head and neck squamous cell carcinoma
    Eldin, N. Bahie
    Mosalem, N.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 37 - 37
  • [7] Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Hamauchi, Satoshi
    Yokota, Tomoya
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Nishimura, Tetsuo
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (12) : 1116 - 1121
  • [8] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [9] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH CAPECITABINE AND CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Gupta, S.
    Khan, H.
    Barik, S.
    Negi, M. P. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S2 - S2
  • [10] Chemoradiation for locally advanced head and neck cancers: Cetuximab or cisplatin?
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2016, 103 (04) : 319 - 319
12345